Search Results - Thomas P. Slavin

Refine Results
  1. 1
    Two-marker association tests yield new disease associations for coronary artery disease and hypertension

    Two-marker association tests yield new disease associations for coronary artery disease and hypertension by Thomas P. Slavin, Tao Feng, Audrey Schnell, Xiaofeng Zhu, Robert C. Elston

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    The effects of genomic germline variant reclassification on clinical cancer care

    The effects of genomic germline variant reclassification on clinical cancer care by Thomas P. Slavin, Sophia Manjarrez, Colin C. Pritchard, Stacy W. Gray, Jeffrey N. Weitzel

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Genetics of gastric cancer: what do we know about the genetic risks?

    Genetics of gastric cancer: what do we know about the genetic risks? by Thomas P. Slavin, Jeffrey N. Weitzel, Susan L. Neuhausen, Kasmintan A. Schrader, Carla Oliveíra, Rachid Karam

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management

    Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management by Thomas P. Slavin, Mariana Niell‐Swiller, Ilana Solomon, Bita Nehoray, Christina Rybak, Kathleen R. Blazer, Jeffrey N. Weitzel

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Clinical, Cytogenetic and Immunophenotype Distribution of Adult Acute Lymphoblastic Leukemia Among Latinos — a Report from a Large Single Institution Cohort in Southern California

    Clinical, Cytogenetic and Immunophenotype Distribution of Adult Acute Lymphoblastic Leukemia Among Latinos — a Report from a Large Single Institution Cohort in Southern California... by Elisa Quiroz, Rebecca A. Nelson, Vinod Pullarkat, Ibrahim Aldoss, Thomas P. Slavin, Eduardo Magalhães Rego, Guido Marcucci, Dan Douer

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Acute Lymphocytic Leukemia in the Latin American Population

    Acute Lymphocytic Leukemia in the Latin American Population by Elisa Quiroz, Rebecca A. Nelson, Ibrahim Aldoss, Vinod Pullarkat, Thomas P. Slavin, Guido Marcucci, Eduardo Magalhães Rego, Dan Douer

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots”

    Systematic misclassification of missense variants in BRCA1 and BRCA2 “coldspots” by Jennifer N. Dines, Brian H. Shirts, Thomas P. Slavin, Tom Walsh, Mary‐Claire King, Douglas M. Fowler, Colin C. Pritchard

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Circulating tumor DNA as an early cancer detection tool

    Circulating tumor DNA as an early cancer detection tool by Andrea Campos-Carrillo, Jeffrey N. Weitzel, Prativa Sahoo, Russell C. Rockne, Janet Mokhnatkin, Muhammed Murtaza, Stacy W. Gray, Laura H. Goetz, Ajay Goel, Nicholas J. Schork, Thomas P. Slavin

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Somatic TP53 variants frequently confound germ-line testing results

    Somatic TP53 variants frequently confound germ-line testing results by Jeffrey N. Weitzel, Elizabeth Chao, Bita Nehoray, Lily R. Van Tongeren, Holly LaDuca, Kathleen R. Blazer, Thomas P. Slavin, Tina Pesaran, Christina Rybak, Ilana Solomon, Mariana Niell‐Swiller, Jill S. Dolinsky, Danielle Castillo, Aaron Elliott, Chia‐Ling Gau, Virginia Speare, Kory Jasperson

    Published 2017
    Get full text Get full text
    Editorial
    Save to List
    Saved in:
  10. 10
    Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry

    Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry by Thomas P. Slavin, Lily R. Van Tongeren, Carolyn E. Behrendt, Ilana Solomon, Christina Rybak, Bita Nehoray, Lili Kuzmich, Mariana Niell‐Swiller, Kathleen R. Blazer, Shu Tao, Kai Yang, Julie O. Culver, Sharon Sand, Danielle Castillo, Josef Herzog, Stacy W. Gray, Jeffrey N. Weitzel

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Pathogenic and likely pathogenic variants in <i>PALB2</i>, <i>CHEK2</i>, and other known breast cancer susceptibility genes among 1054 <i>BRCA</i>‐negative Hispanics with breast cancer

    Pathogenic and likely pathogenic variants in <i>PALB2</i>, <i>CHEK2</i>, and other known breast cancer susceptibility genes among 1054 <i>BRCA</i>‐negative Hispanics with breast ca... by Jeffrey N. Weitzel, Susan L. Neuhausen, Aaron W. Adamson, Shu Tao, Charité Ricker, Asaf Maoz, Margalit Rosenblatt, Bita Nehoray, Sharon Sand, Linda Steele, Gary Unzeitig, Nancy Feldman, Amie Blanco, Donglei Hu, Scott Huntsman, Danielle Castillo, Christopher A. Haiman, Thomas P. Slavin, Elad Ziv

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Germline Genetic Testing After Cancer Diagnosis

    Germline Genetic Testing After Cancer Diagnosis by Allison W. Kurian, Paul Abrahamse, Allison Furgal, Kevin C. Ward, Ann S. Hamilton, Rachel Hodan, Rachel Tocco, Lihua Liu, Jonathan S. Berek, Lily Hoang, Amal Yussuf, Lisa R. Susswein, Edward D. Esplin, Thomas P. Slavin, Scarlett Lin Gomez, Timothy P. Hofer, Steven J. Katz

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative

    Performance of the IBIS/Tyrer‐Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative by Allison W. Kurian, Elisha Hughes, Timothy Simmons, Ryan Bernhisel, Braden Probst, Stephanie Meek, Jennifer L. Caswell‐Jin, Esther M. John, Jerry S. Lanchbury, Thomas P. Slavin, Susanne Wagner, Alexander Gutin, Thomas E. Rohan, Aladdin H. Shadyab, JoAnn E. Manson, Dorothy S. Lane, Rowan T. Chlebowski, Marcia L. Stefanick

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network

    Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network by Thomas P. Slavin, Susan L. Neuhausen, Christina Rybak, Ilana Solomon, Bita Nehoray, Kathleen R. Blazer, Mariana Niell‐Swiller, Aaron W. Adamson, Yuan Yuan, Kai Yang, Sharon Sand, Danielle Castillo, Josef Herzog, Xiwei Wu, Shu Tao, Tanya Chavez, Yanghee Woo, Joseph Chao, Pamela Mora, Darling J Horcasitas, Jeffrey N. Weitzel

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer

    Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer by Kara N. Maxwell, Steven N. Hart, Joseph Vijai, Kasmintan A. Schrader, Thomas P. Slavin, Tinu Thomas, Bradley Wubbenhorst, Vignesh Ravichandran, Raymond M. Moore, Chunling Hu, Lucia Guidugli, Brandon M. Wenz, Susan M. Domchek, Mark E. Robson, Csilla I. Szabo, Susan L. Neuhausen, Jeffrey N. Weitzel, Kenneth Offit, Fergus J. Couch, Katherine L. Nathanson

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to <i>de novo</i> acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients

    Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to <i>de novo</i> acute lymphoblastic leukemia, but outcomes are comparable in... by Ibrahim Aldoss, Tracey Stiller, Ni‐Chun Tsai, Joo Y. Song, Thai M. Cao, N. Achini Bandara, Amandeep Salhotra, Samer K. Khaled, Ahmed Aribi, Monzr M. Al Malki, Matthew Mei, Haris Ali, Ricardo Spielberger, Margaret O’Donnell, David S. Snyder, Thomas P. Slavin, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

    Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer by Bradon R. McDonald, Tania Contente‐Cuomo, Stephen‐John Sammut, Ahuva Odenheimer-Bergman, Brenda Ernst, Nieves Perdigones, Suet‐Feung Chin, Maria Farooq, Rosa Mejia, Patricia A. Cronin, Karen S. Anderson, Heidi E. Kosiorek, Donald W. Northfelt, Ann E. McCullough, Bhavika K. Patel, Jeffrey N. Weitzel, Thomas P. Slavin, Carlos Caldas, Barbara A. Pockaj, Muhammed Murtaza

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing

    Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing by Thomas P. Slavin, Kimberly C. Banks, Darya Chudova, Geoffrey R. Oxnard, Justin I. Odegaard, Rebecca J. Nagy, Kar Wing Kevin Tsang, Susan L. Neuhausen, Stacy W. Gray, Massimo Cristofanilli, Angel Rodriguez, Aditya Bardia, Brian Leyland‐Jones, Mike F. Janicek, Michael B. Lilly, Guru Sonpavde, Christine E. Lee, Richard B. Lanman, Funda Meric‐Bernstam, Razelle Kurzrock, Jeffrey N. Weitzel

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Specifications of the ACMG/AMP variant interpretation guidelines for germline <i>TP53</i> variants

    Specifications of the ACMG/AMP variant interpretation guidelines for germline <i>TP53</i> variants by Cristina Fortuño, Kristy Lee, Magali Olivier, Tina Pesaran, L. Phuong, Kelvin C. de Andrade, Laura D. Attardi, Stephanie B. Crowley, D. Gareth Evans, Bing Feng, Ann Katherine M. Foreman, Megan N. Frone, Robert Huether, Paul A. James, Kelly McGoldrick, Jessica L. Mester, Bryce A. Seifert, Thomas P. Slavin, Leora Witkowski, Liying Zhang, Sharon E. Plon, Amanda B. Spurdle, Sharon A. Savage

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors

    Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors by Brent Mabey, Elisha Hughes, Matthew Kucera, Timothy Simmons, Brooke Hullinger, Holly J. Pederson, Lamis Yehia, Charis Eng, Judy E. Garber, Monique Gary, Ora Gordon, Jennifer R. Klemp, Semanti Mukherjee, Joseph Vijai, Kenneth Offit, Olufunmilayo I. Olopade, Sandhya Pruthi, Allison W. Kurian, Mark E. Robson, Pat W. Whitworth, Tuya Pal, Sarah Ratzel, Susanne Wagner, Jerry S. Lanchbury, Katherine Johansen Taber, Thomas P. Slavin, Alexander Gutin

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: